Ignite Creation Date:
2025-12-25 @ 4:50 AM
Ignite Modification Date:
2026-05-17 @ 8:53 PM
Study NCT ID:
NCT06059118
Status:
RECRUITING
Last Update Posted:
2025-02-25
First Post:
2023-09-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer
Sponsor:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
J2326
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None